News for 'SARS CoV'

Researchers spot distinct features in lungs of COVID-19 victims

Researchers spot distinct features in lungs of COVID-19 victims

Rediff.com22 May 2020

According to the study, both SARS-CoV-2 and H1N1 are the same category of virus, and both infect the respiratory tract. While the lungs of both groups shared some common features, the scientists said there were distinctive features related to blood vessels seen in the lungs of patients who had died due to COVID-19.

'Everybody need not rush to hospital'

'Everybody need not rush to hospital'

Rediff.com7 Jan 2022

'If your oxygen saturation is okay and is maintained after the six-minute walk test -- which has been described all over the world -- and you do not have an unrelenting fever, then you can even be managed at home.'

Cotton, silk, chiffon best materials for masks: Study

Cotton, silk, chiffon best materials for masks: Study

Rediff.com25 Apr 2020

The scientists assessed the ability of common fabrics, alone or in combination, to filter out aerosols similar in size to respiratory droplets.

Lockdown will no longer help in COVID-19 fight: Virologist

Lockdown will no longer help in COVID-19 fight: Virologist

Rediff.com23 May 2020

Shahid Jameel, recipient of Shanti Swarup Bhatnagar Prize for Science and Technology, also said that the country had already reached community transmission a long time ago.

COVID-19 test method developed by IIT Delhi gets ICMR nod

COVID-19 test method developed by IIT Delhi gets ICMR nod

Rediff.com23 Apr 2020

IIT Delhi is the first academic institute to have obtained the ICMR approval for a real-time PCR- based diagnostic assay. The development also comes against the backdrop of the Indian Council of Medical Research halting the testing for COVID-19 cases through China-made test kits because of massive variation in test results, compounding the challenge to check and contain the pandemic.

India expects 500 million doses of Covid vaccine by July 2021

India expects 500 million doses of Covid vaccine by July 2021

Rediff.com13 Oct 2020

"Keeping a close pace with the potential availability of vaccine, a plan of action on which sections are to be given priority has been discussed. Importantly, it would be monitored through a scientific approach," Dr Harsh Vardhan told ANI about the strategy being discussed on vaccine distribution.

Antibodies that can neutralise Omicron, other variants identified

Antibodies that can neutralise Omicron, other variants identified

Rediff.com29 Dec 2021

Scientists have identified antibodies that neutralise Omicron and other variants of coronavirus by targeting areas that remain essentially unchanged as the virus mutates.

Delta variant 8 times less sensitive to vaccines: Study

Delta variant 8 times less sensitive to vaccines: Study

Rediff.com5 Jul 2021

The study, which was conducted on more than 100 healthcare workers at three centres in India including Sir Ganga Ram Hospital, found that the B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-Delta infections (Ct value of 16.5 versus 19) but also generates greater transmission among the fully vaccinated HCWs.

Covid survives longer on glass, plastic than on cloth, paper: IIT Bombay study

Covid survives longer on glass, plastic than on cloth, paper: IIT Bombay study

Rediff.com15 Feb 2021

A study by researchers from the Indian Institute of Technology Bombay found that a droplet remains liquid for a much shorter time on a porous surface, making it less favourable to the survival of the virus.

Covid likely came from lab leak in China: Report

Covid likely came from lab leak in China: Report

Rediff.com27 Feb 2023

The new report highlights how different parts of the intelligence community have arrived at disparate judgments about the pandemic's origin.

Pfizer jab produces less antibodies against Delta variant: Study

Pfizer jab produces less antibodies against Delta variant: Study

Rediff.com4 Jun 2021

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

'The severe cases are mostly unvaccinated people'

'The severe cases are mostly unvaccinated people'

Rediff.com28 Dec 2021

'In our ICUs, the majority are unvaccinated people.' 'Out of the hospital, in the community, we see that -- whether you are vaccinated or whether you're not vaccinated -- the symptoms are more or less the same.'

Covid like a Test match, not ODI: AIIMS taskforce chief

Covid like a Test match, not ODI: AIIMS taskforce chief

Rediff.com20 May 2021

Chairperson of the COVID Task Force for All India Institute of Medical Sciences, Dr Naveet Wig on Thursday said that the COVID-19 crisis is 'a dynamic situation' and to prevent a third wave of the pandemic, there is a need to keep changing strategies.

57% of Mumbai's slum dwellers have covid antibodies: Study

57% of Mumbai's slum dwellers have covid antibodies: Study

Rediff.com29 Jul 2020

The sero-surveillance started on June 3 and 6,936 samples out of an estimated 8,870 were collected from slum and non-slum population of three civic wards -- R-North, M-West and F-North -- in the first half of July.

'New Covid surge is a seasonal wave but spreads faster'

'New Covid surge is a seasonal wave but spreads faster'

Rediff.com18 Mar 2024

'Seek medical help if after five days of the first symptom the fever has not subsided.'

Maha to issue revised air travel guidelines 'in a couple of days'

Maha to issue revised air travel guidelines 'in a couple of days'

Rediff.com2 Dec 2021

Tope's comments came a day after the Centre asked the state to align its order with the SOPs issued by the Union health ministry.

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

Rediff.com15 Jul 2020

The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.

'Indian strain' of coronavirus spreads faster: Experts

'Indian strain' of coronavirus spreads faster: Experts

Rediff.com27 Apr 2021

The B.1.617 variant of SARS-CoV2, also being called a 'double mutant' or the 'Indian strain', has been found prevalent largely in Maharashtra and Delhi that have been severely hit by a devastating second wave of the pandemic.

Surge in Covid cases indicates endemicity: Experts

Surge in Covid cases indicates endemicity: Experts

Rediff.com7 Apr 2023

'These number surges will be the outcome of emerging virus variants, loss of vaccine- or infection-acquired protective immunity in people, and environmental factors'

Govt plans rapid pool testing of migrants, returnees from abroad

Govt plans rapid pool testing of migrants, returnees from abroad

Rediff.com14 May 2020

The same testing technique would also be used for monitoring in green zones districts which have reported no cases till now or in the last 21 days, the Union health ministry said while issuing 'Guidelines for RT-PCR based pooled sampling for migrants/returnees from abroad/green zones'.

New Covid strains may lead to spike in hospitalisation, fear experts

New Covid strains may lead to spike in hospitalisation, fear experts

Rediff.com27 Oct 2022

An immune-escape Covid-19 strain coupled with the natural spike in influenza and pneumonia cases during winters may lead to a rise in hospitalisation.

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

Study reveals how countries can avoid future Covid-19 surges

Study reveals how countries can avoid future Covid-19 surges

Rediff.com22 Feb 2021

A combination of robust vaccination programmes and strict physical distancing rules may be enough to prevent recurring peaks of COVID-19 without greatly restricting the mobility of people, according to a modelling study.

Govt issues new guidelines for international arrivals

Govt issues new guidelines for international arrivals

Rediff.com18 Feb 2021

The government on Wednesday issued new guidelines for international arrivals amid the spread of mutant variants of coronavirus in many countries.

Centre remains on high-alert for new Covid variants

Centre remains on high-alert for new Covid variants

Rediff.com20 Jun 2023

COVID-19 is on the verge of becoming endemic but Indian scientists are keeping a close watch on each new variant and the government would continue to maintain a high alert, Union health minister Mansukh Mandaviya has said, underlining that the virus has managed to survive and is going to stay.

Vaxed pregnant women pass antibodies to babies: Study

Vaxed pregnant women pass antibodies to babies: Study

Rediff.com23 Sep 2021

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, according to a study.

Which way is Covid-19 headed?

Which way is Covid-19 headed?

Rediff.com18 Mar 2020

The disease could go down several paths. One possibility, the least likely, is that it will just disappear. The most likely is that it will have seasonal impact, says Devangshu Datta.

Good news! Fall in new Covid cases in Kerala, Maharashtra

Good news! Fall in new Covid cases in Kerala, Maharashtra

Rediff.com18 Aug 2021

After breaching the value of 1 in the first week of August, the R number, which reflects how rapidly the coronavirus pandemic is spreading, has been steadily ebbing, according to researchers at the Institute of Mathematical Sciences, Chennai.

Oxford COVID-19 vaccine hopes rise with strong trial results

Oxford COVID-19 vaccine hopes rise with strong trial results

Rediff.com16 Jul 2020

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and 'killer T-cells', a senior source from the trial was quoted by The Daily Telegraph as saying.

Long Covid has more than 200 symptoms: Study

Long Covid has more than 200 symptoms: Study

Rediff.com15 Jul 2021

The most common symptoms were fatigue, post-exertional malaise -- worsening of symptoms after physical or mental exertion -- and cognitive dysfunction, often called brain fog.

Mumbai, Delhi, Guj report big spike in new Covid cases

Mumbai, Delhi, Guj report big spike in new Covid cases

Rediff.com29 Dec 2021

The spike in the country's financial capital has got pronounced since December 20, when just 283 cases were reported. Tuesday had witnessed 1,377 cases in the metropolis, and Wednesday's figure was a jump by over 80 per cent, he pointed out.

Centre issues alert to states over Tomato Flu in children

Centre issues alert to states over Tomato Flu in children

Rediff.com24 Aug 2022

Centre has sent an advisory to states on HFMD (Hand Foot and Mouth Disease), commonly known as Tomato Flu, stating that it's a self-limiting illness targeting mostly young children aged 1-10 years and immune-compromised adults and no specific drug exists to treat it.

'Vaccine Must Go To Older People First'

'Vaccine Must Go To Older People First'

Rediff.com9 Nov 2021

'At the current time, we should be vaccinating all those who are potentially going to get more severe illness, before we start vaccinating very young individuals.'

WHO criticises China for withholding Covid origin data

WHO criticises China for withholding Covid origin data

Rediff.com18 Mar 2023

"We continue to call on China to be transparent in sharing data and to conduct the necessary investigations and share the results. Understanding how the pandemic began remains both a moral and scientific imperative," Ghebreyesus said.

'No need to give special attention to COVID-19 anymore'

'No need to give special attention to COVID-19 anymore'

Rediff.com22 Aug 2022

'All actions for COVID-19 should be the same as for other routine health conditions.' 'There is no need to report the matter in the media all the time; not on front page please.'

Worst days of Covid over, but pandemic will be with us for ever: US official

Worst days of Covid over, but pandemic will be with us for ever: US official

Rediff.com8 Nov 2022

With variants cropping up at regular intervals, Jha acknowledged that they are a concern as a very rapid evolution of this virus is being seen over the time.

Delta variant 'greatest threat' to US Covid response: Dr Fauci

Delta variant 'greatest threat' to US Covid response: Dr Fauci

Rediff.com23 Jun 2021

However, the "good news" is that the US vaccines are effective against the Delta variant, said Fauci, the head of the National Institutes of Allergy and Infectious Diseases.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

Bharat Biotech to make 900 million Covaxin vaccines

Bharat Biotech to make 900 million Covaxin vaccines

Rediff.com1 Jun 2021

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.

How COVID-19 affects the heart

How COVID-19 affects the heart

Rediff.com7 Dec 2020

'The more seriously ill you are from heart disease, the more seriously ill you could get from infection with COVID-19.'